Suppression of myeloid cell arginase activity leads to therapeutic response in Kras mutant lung cancer by activating anti-tumor immunity

被引：0
|
作者：
Miret, Juan J. [1 ]
Kirschmeier, Paul [1 ]
Wu, Min [1 ]
Huang, Wei [1 ]
Walker, William [1 ]
Palakurti, Sangeetha [1 ]
Saccomano, Nick [2 ]
Hammerman, Peter S. [1 ]
Wong, Kwok-Kin [3 ]
Akbay, Esra [4 ]
机构：
[1] Dana Farber Canc Inst, Belfer Inst, Boston, MA 02115 USA
[2] Array Biopharma, Boulder, CO USA
[3] NYU, Div Hematol & Med Oncol, Boston, MA USA
[4] UT Southwestern Med Ctr, Dallas, TX USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-4065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4065
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Apoptotic but not necrotic tumor cell death leads to efficient anti-tumor immune response
    不详
    IMMUNOBIOLOGY, 2005, 210 (6-8) : 469 - 469
  • [22] ANTI-TUMOR IMMUNITY IN BREAST-CANCER PATIENTS - BIOLOGIC AND THERAPEUTIC IMPLICATIONS
    BLACK, MM
    ZACHRAU, RE
    JOURNAL OF REPRODUCTIVE MEDICINE, 1979, 23 (01) : 21 - 32
  • [23] Cytokine Adjuvanation of Therapeutic Anti-tumor Immunity Targeted to Cancer Mucosa Antigens
    Snook, Adam E.
    Huang, Lan
    Schulz, Stephanie
    Eisenlohr, Laurence C.
    Waldman, Scott A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2008, 1 (03): : 263 - 264
  • [24] BET bromodomain inhibition synergizes with immune checkpoint blockade to facilitate anti-tumor response in a murine model of non-small cell lung cancer harboring activating KRAS mutation
    Adeegbe, Dennis O.
    Freeman, Gordon J.
    Wong, Kwok-Kin
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [25] IL-7 enhances the anti-tumor response in nonsmall cell lung cancer
    Yang, Seok Chul
    Kim, Young Whan
    You, Chul-Gyu
    Lee, San Min
    Lee, Choon-Taek
    Han, Sung Koo
    Shim, Young-Soo
    Lim, Jae-Jun
    Hillinger, Sven
    Zhu, Li
    Dubinett, Steven M.
    Sharma, Sherven
    CHEST, 2007, 132 (04) : 458S - 458S
  • [26] Controlling Cancer Cell Death Types to Optimize Anti-Tumor Immunity
    Metzig, Marie Oliver
    Hoffmann, Alexander
    BIOMEDICINES, 2022, 10 (05)
  • [27] STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity
    Glickman, Laura Hix
    Kanne, David B.
    Kasibhatla, Shailaja
    Li, Jie
    Pferdekamper, AnneMarie Culazzo
    Gauthier, Kelsey Sivick
    Deng, Weiwen
    Desbien, Anthony L.
    Katibah, George E.
    Leong, Justin J.
    Sung, Leonard
    Metchette, Ken
    Ndubaku, Chudi
    Zheng, Lianxing
    Cho, Charles
    Feng, Yan
    McKenna, Jeffrey M.
    Tallarico, John A.
    Bender, Steven L.
    Dubensky, Thomas W.
    McWhirter, Sarah M.
    CANCER RESEARCH, 2016, 76
  • [28] THC-mediated, IL-10-dependent suppression of anti-tumor immunity of murine lung cancer.
    Zhu, L
    Sharma, S
    Stolina, M
    Gardner, B
    Roth, M
    Tashkin, D
    Dubinett, SM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A404 - A404
  • [29] SUPPRESSION OF CELL-MEDIATED ANTI-TUMOR IMMUNITY BY COMPLETE FREUNDS-ADJUVANT
    KOYAMA, S
    YOSHIOKA, T
    SAKITA, T
    CANCER RESEARCH, 1982, 42 (08) : 3215 - 3219
  • [30] The anti-tumor immune response in breast cancer: Update and therapeutic perspectives
    Ladoire, Sylvain
    Derangere, Valentin
    Arnould, Laurent
    Thibaudin, Marion
    Coudert, Bruno
    Lorgis, Veronique
    Desmoulins, Isabelle
    Chaix, Marie
    Fumoleau, Pierre
    Ghiringhelli, Francois
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 133 - 141
12345